GMED
GMED
US3795772082
Globus Medical, Inc.
Loading chart...

Company Profile

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Latest News

Related stocks

BIO
BIO • United States
Bio-Rad Laboratories, Inc.
366.16 USD
9.8B USD 1Y +19%
PODD
PODD • United States
Insulet Corporation
135.28 USD
9.38B USD 1Y -57.4%
GKOS
GKOS • United States
Glaukos Corporation
165.69 USD
9.77B USD 1Y +84.1%
BRKR
BRKR • United States
Bruker Corporation
58.84 USD
8.96B USD 1Y +67.3%
PEN
PEN • United States
Penumbra, Inc.
319.4 USD
12.58B USD 1Y +22.6%
STE
STE • United States
STERIS plc (Ireland)
214.4 USD
20.9B USD 1Y -13%
HAE
HAE • United States
Haemonetics Corporation
118.69 USD
5.4B USD 1Y +134.3%
ZBH
ZBH • United States
Zimmer Biomet Holdings, Inc.
89.14 USD
17B USD 1Y -9.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
38.5% p.a.
Max Drawdown (5Y)
-46.2%
Sharpe Ratio (5Y)
-0.08
Beta Factor
0.96
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (38.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -47.9% in the extended horizon.
ende